Teladoc Health (NYSE:TDOC – Get Free Report) had its price target hoisted by Citigroup from $9.50 to $10.50 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the health services provider’s stock. Citigroup’s price objective would suggest a potential upside of 26.28% from the stock’s current price.
A number of other research firms also recently weighed in on TDOC. Mizuho started coverage on shares of Teladoc Health in a research report on Friday, July 25th. They set a “neutral” rating and a $10.00 target price for the company. Zacks Research upgraded shares of Teladoc Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 10th. Evercore ISI lifted their target price on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Teladoc Health in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Teladoc Health currently has an average rating of “Hold” and a consensus target price of $9.97.
Check Out Our Latest Report on TDOC
Teladoc Health Stock Performance
Teladoc Health (NYSE:TDOC – Get Free Report) last announced its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.08. The firm had revenue of $631.90 million for the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The business’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. Sell-side analysts expect that Teladoc Health will post -1.16 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Golden State Wealth Management LLC increased its holdings in shares of Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its position in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,581 shares during the period. SVB Wealth LLC bought a new stake in Teladoc Health during the 1st quarter valued at $37,000. BI Asset Management Fondsmaeglerselskab A S acquired a new position in Teladoc Health during the first quarter worth $50,000. Finally, Caitong International Asset Management Co. Ltd raised its holdings in Teladoc Health by 8,192.0% during the second quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock worth $72,000 after buying an additional 8,192 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
- Five stocks we like better than Teladoc Health
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- Which Wall Street Analysts are the Most Accurate?
- The Best AI for Picking Stocks, Ranked by Performance
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
